Findings

What do systematic reviews say?

65 questions · 65 findings · 5 reviews · Musculoskeletal

No studies found 31 · 47.7%GRADE not reported 1 · 1.5%Very low 0 · 0%Low 12 · 18.5%Moderate 14 · 21.5%High 7 · 10.8%

Pain · people with chronic gout

The review found no eligible studies for this question.

1 finding from 1 review

Febuxostat for treating chronic gout 2012 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Patient global assessment · people with chronic gout

The review found no eligible studies for this question.

1 finding from 1 review

Febuxostat for treating chronic gout 2012 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Health related quality of life · people with chronic gout

The review found no eligible studies for this question.

1 finding from 1 review

Febuxostat for treating chronic gout 2012 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Serious adverse events · people with chronic gout

Febuxostat 120 mg/day showed no clear difference in serious Adverse Events compared with allopurinol (high certainty).

1 finding from 1 review

Febuxostat for treating chronic gout 2012 · Cochrane Headline outcomes only
RR 1.2 [0.7, 1.93]
3 studies · 1041 participants
High

Withdrawals due to adverse events · people with chronic gout

Febuxostat 120 mg/day showed no clear difference in discontinuations due to adverse events compared with allopurinol (high certainty).

1 finding from 1 review

Febuxostat for treating chronic gout 2012 · Cochrane Headline outcomes only
RR 1.6 [0.49, 5]
3 studies · 1041 participants
High